Filed in archive
News
, Treatment
by Gloria Gamat on April 18, 2007
Both oral blood glucose lowering drugs, glipizide and metformin are used for the treatment of type 2 diabetes when diet alone is not sufficient, but with different mechanisms of action: glipizide by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently while metformin hydrochloride, by decreasing sugar production and absorption and helping your body respond better to its own insulin.
Glipizide's popular brand is Glucotrol® by Pfizer while metformin hydrochloride is known as the brand Glucophage®, a product of Bristol-Myers Squibb.
Additionally, these two blood glucose-lowering ingredients are found in one product: Bristol-Myers Squibb's Metaglip™ Tablets.
Thanks to Mylan Pharmaceuticals, Metaglip™ now has a USFDA-approved generic counterpart.
Source: Mylan Laboratories, Inc.
Permalink: Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/64265
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA:
|
Rating: 8.33 out of 3 vote(s) cast.
|
Response from:
Trusted.MD Network
The first generic versions of Risperdal (risperidone) tablets has recently been approved by the FDA.
Response from:
Trusted.MD Network
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
